bf/NASDAQ:NARI_icon.png

COM:INARIMEDICAL

Inari Medical

  • Stock

Last Close

49.75

22/11 21:00

Market Cap

3.00B

Beta: -

Volume Today

590.81K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-10.15M
-
-1.19M
88.26%
13.79M
1,256.97%
9.84M
28.64%
-29.27M
397.43%
-1.64M
94.41%
depreciation and amortization
283K
-
613.52K
116.79%
1.39M
125.75%
4.31M
211.05%
7.12M
65.25%
10.74M
50.93%
deferred income tax
144K
-
1.30M
799.93%
4.20M
224.25%
47K
98.88%
-584K
-
stock based compensation
248K
-
504.80K
103.55%
3.52M
598.10%
25.45M
622.13%
28.67M
12.67%
40.34M
40.69%
change in working capital
-1.52M
-
-6.26M
311.80%
-21.17M
238.20%
-14.30M
32.45%
-21.47M
50.13%
2.64M
112.29%
accounts receivables
-2.17M
-
-8.95M
313.62%
-16.71M
86.56%
-14.36M
14.04%
-17.03M
18.59%
-11.05M
35.09%
inventory
-558K
-
-2.87M
415.02%
-6.64M
131.19%
-10.49M
57.86%
-11.69M
11.44%
-7.44M
36.36%
accounts payables
372K
-
1.83M
393.20%
498K
72.86%
3.51M
605.62%
1.14M
67.56%
344K
69.82%
other working capital
831K
-
3.73M
349.42%
1.68M
54.94%
7.04M
318.00%
6.11M
13.15%
20.79M
240.20%
other non cash items
106K
-
101.00K
4.71%
181K
79.20%
143K
20.99%
973K
580.42%
-15.57M
1,700.51%
net cash provided by operating activities
-10.89M
-
-4.94M
54.68%
1.91M
138.74%
25.49M
1,232.95%
-13.97M
154.82%
35.93M
357.14%
investments in property plant and equipment
-753K
-
-3.14M
317.55%
-5.46M
73.66%
-13.64M
149.91%
-9.95M
27.07%
-6.20M
37.68%
acquisitions net
37.38M
-
185.26M
395.67%
-240.42M
229.77%
purchases of investments
-49.98M
-
-134.38M
168.88%
-497.87M
270.50%
-406.74M
18.30%
sales maturities of investments
97M
-
312.60M
222.27%
595.34M
90.45%
other investing activites
-37.38M
-
-185.26M
395.67%
net cash used for investing activites
-753K
-
-3.14M
317.55%
-55.44M
1,663.19%
-51.02M
7.96%
-195.22M
282.61%
-58.02M
70.28%
debt repayment
-10.14M
-
-30.25M
198.32%
common stock issued
127.21K
-
164.36M
129,106.50%
6.43M
96.09%
174.40M
2,613.47%
10.74M
93.84%
common stock repurchased
-25K
-
5.56M
22,332%
8.42M
51.53%
9.92M
17.80%
dividends paid
-25K
-
other financing activites
26.76M
-
20.24M
24.37%
10.05M
50.32%
-7.91M
178.70%
-5.68M
28.22%
-19.50M
243.28%
net cash used provided by financing activities
26.76M
-
10.22M
61.79%
144.12M
1,309.64%
4.07M
97.17%
177.14M
4,249.08%
1.17M
99.34%
effect of forex changes on cash
-402K
-
-480K
19.40%
-94K
80.42%
net change in cash
15.11M
-
2.14M
85.82%
90.59M
4,126.28%
-21.86M
124.14%
-32.53M
48.78%
-21.01M
35.40%
cash at beginning of period
6.77M
-
21.88M
223.20%
24.03M
9.79%
114.62M
377.03%
92.75M
19.08%
60.22M
35.07%
cash at end of period
21.88M
-
24.03M
9.79%
114.62M
377.03%
92.75M
19.08%
60.22M
35.07%
39.21M
34.89%
operating cash flow
-10.89M
-
-4.94M
54.68%
1.91M
138.74%
25.49M
1,232.95%
-13.97M
154.82%
35.93M
357.14%
capital expenditure
-753K
-
-3.14M
317.55%
-5.46M
73.66%
-13.64M
149.91%
-9.95M
27.07%
-6.20M
37.68%
free cash flow
-11.64M
-
-8.08M
30.61%
-3.55M
56.09%
11.84M
433.74%
-23.92M
302.04%
29.73M
224.26%

All numbers in (except ratios and percentages)